Inventor · disambiguated record
Bernard Roizman
Also filed as: ROIZMAN BERNARD
39 granted patents·16 pending applications·1,147 citations·filing 1981–2019
98Inventor score
Files withARCH DEV CORP24UNIV CHICAGO16KHODAREV NIKOLAI2MERIEUX INST2SHENZHEN INTERNATIONAL INSTITUTE FOR BIOMEDICAL RES2
Top patents by PatentIndex Score
55 records- 0195US5328688ARecombinant herpes simplex viruses vaccines and methodsARCH DEV CORP·Filed 1990·Granted Jul 12, 1994·160 cites·45 claims
- 0295US4859587ARecombinant herpes simplex viruses, vaccines and methodsMERIEUX INST·Filed 1986·Granted Aug 22, 1989·103 cites·51 claims
- 0394US5288641AHerpes Simplex virus as a vectorARCH DEV CORP·Filed 1992·Granted Feb 22, 1994·227 cites·62 claims
- 0491US7744899B2Recombinant herpes simplex virus useful for treating neoplastic diseaseUNIV CHICAGO·Filed 2006·Granted Jun 29, 2010·17 cites·28 claims
- 0591US4769331ARecombinant methods and materialsUNIVERSITY PATENTS INC·Filed 1985·Granted Sep 6, 1988·141 cites·9 claims
- 0690US6846670B2Genetically engineered herpes virus for the treatment of cardiovascular diseaseUNIV CHICAGO·Filed 2001·Granted Jan 25, 2005·32 cites·28 claims
- 0789US7892740B2Prognosis and therapy predictive markers and methods of useUNIV CHICAGO·Filed 2007·Granted Feb 22, 2011·20 cites·23 claims
- 0886US9790504B2Anti-tumor therapyKHODAREV NIKOLAI·Filed 2014·Granted Oct 17, 2017·9 cites·5 claims
- 0986US9669036B2Modulation of reactivation of a latent virusUNIV CHICAGO·Filed 2014·Granted Jun 6, 2017·10 cites·11 claims
- 1084US5599691AHerpes simplex virus as a vectorARCH DEV CORP·Filed 1995·Granted Feb 4, 1997·45 cites·23 claims
- 1179US5846707AHerpes simplex virus as a vectorARCH DEV CORP·Filed 1997·Granted Dec 8, 1998·33 cites·23 claims
- 1278US8772261B2Treatment of tumors with genetically engineered herpes virusARCH DEV CORP·Filed 2012·Granted Jul 8, 2014·1 cites·6 claims
- 1378US6723511B2Herpes simplex virus ICP4 is an inhibitor of apoptosisARCH DEV CORP·Filed 2001·Granted Apr 20, 2004·6 cites·12 claims
- 1477US5876923AHerpes simplex virus ICP4 as an inhibitor of apoptosisARCH DEV CORP·Filed 1996·Granted Mar 2, 1999·42 cites·8 claims
- 1576US7550148B2Targeting of Herpes simplex virus to specific receptorsUNIV CHICAGO·Filed 2005·Granted Jun 23, 2009·2 cites·23 claims
- 1676US6172047B1Method of screening candidate protective, potentiating, or inhibiting substancesARCH DEV CORP·Filed 1995·Granted Jan 9, 2001·37 cites·6 claims
- 1775US4554159AVaccine and method of immunizing against herpes simplex virus (types 1 and 2)MERIEUX INST·Filed 1981·Granted Nov 19, 1985·40 cites·31 claims
- 1873US6340673B1Method of treating tumorigenic diseaseARCH DEV CORP·Filed 1999·Granted Jan 22, 2002·30 cites·6 claims
- 1972US8318691B2Treatment of tumors with genetically engineered herpes virusWEICHSELBAUM RALPH R·Filed 2010·Granted Nov 27, 2012·1 cites·16 claims
- 2071US8927251B2Targeting of herpes simplex virus to specific receptorsZHOU GUOYING·Filed 2006·Granted Jan 6, 2015·2 cites·46 claims
- 2171US6071692AHerpes simplex virus as a vectorARCH DEV CORP·Filed 1998·Granted Jun 6, 2000·20 cites·22 claims
- 2269US6120773ARecombinant herpes simplex viruses vaccines and methodsARCH DEV CORP·Filed 1994·Granted Sep 19, 2000·25 cites·28 claims
- 2365US7501126B2Targeting of herpes simplex virus to specific receptorsUNIV CHICAGO·Filed 2003·Granted Mar 10, 2009·2 cites·13 claims
- 2465US5834216AScreening methods for the identification of inducers and inhibitors of programmed cell death (apoptosis)ARCH DEV CORP·Filed 1995·Granted Nov 10, 1998·30 cites·17 claims
- 2565US5478727AMethods and compositions for the preparation and use of a herpes proteaseARCH DEV CORP·Filed 1992·Granted Dec 26, 1995·22 cites·11 claims
- 2664US2019071679A1Anti-tumor therapyUNIV CHICAGO·Filed 2018·Application pending·0 cites
- 2761US5922328AMethods and compositions for treatment of HSV-2 infections and conditionsAVIRON INC·Filed 1996·Granted Jul 13, 1999·19 cites·7 claims
- 2859US7592169B2Methods and compositions for treatment and prevention of HSV-2 infections and conditionsMEDIMMUNE LLC·Filed 2004·Granted Sep 22, 2009·0 cites·1 claims
- 2958US6383738B1Herpes simplex virus ORF P is a repressor of viral protein synthesisARCH DEV CORP·Filed 1998·Granted May 7, 2002·18 cites·14 claims
- 3057US6218103B1Herpes simplex virus US3 and ICP4 as inhibitors of apoptosisARCH DEV CORP·Filed 1997·Granted Apr 17, 2001·10 cites·20 claims
- 3157US2017298362A1Anti-tumor therapyUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 3256US2008014175A1Methods and Compositions for Viral Enhancement of Cell KillingUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 3355US6210926B1Herpes simplex virus ICP4 is an inhibitor of apoptosisARCH DEV CORP·Filed 1999·Granted Apr 3, 2001·8 cites·10 claims
- 3455US2003207829A9Treatment of tumors with genetically engineered herpes virusARCH DEV CORP·Filed 2001·Application pending·0 cites
- 3554US10561708B2Anti-tumor therapyUNIV CHICAGO·Filed 2018·Granted Feb 18, 2020·0 cites·17 claims
- 3654US2013150258A1Prognosis and therapy predictive markers and methods of useUNIV CHICAGO·Filed 2013·Application pending·0 cites
- 3754US2005147591A1Methods and compositions for viral enhancement of cell killingFiled 2004·Application pending·0 cites
- 3853US2011274661A1Attentuated Herpesvirus Encoding a Mek Pathway PolypeptideUNIV CHICAGO·Filed 2009·Application pending·0 cites
- 3952US5846948AHerpes simplex virus ORF P is a repressor of viral protein synthesisARCH DEV CORP·Filed 1996·Granted Dec 8, 1998·9 cites·8 claims
- 4051US9803006B2Targeting of herpes simplex virus to specific receptorsUNIV CHICAGO·Filed 2015·Granted Oct 31, 2017·0 cites·6 claims
- 4150US2011200998A1Prognosis and Therapy Predictive Markers and Methods of UseUNIV CHICAGO·Filed 2011·Application pending·0 cites
- 4249US2010221228A1y134.5 Deficient HSV and the MAPK PathwayUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 4347US5641651ASynthetic herpes simplex virus promotersARCH DEV CORP·Filed 1994·Granted Jun 24, 1997·6 cites·16 claims
- 4446US2016367627A1Anti-tumor therapyKHODAREV NIKOLAI·Filed 2014·Application pending·0 cites
- 4546US2022347243A1Pharmaceutical compositions, kits and methods for treating tumorsIMMVIRA CO LTD·Filed 2019·Application pending·0 cites
- 4645US5714153AMethod of inducing antibody production against an infectious agent in a hostARCH DEV CORP·Filed 1996·Granted Feb 3, 1998·4 cites·10 claims
- 4745US2007243170A1Targeting of Herpes Simplex Virus to Specific ReceptorsUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 4844US11026990B2PUM 1 protein as target for virus inhibitionSHENZHEN INTERNATIONAL INSTITUTE FOR BIOMEDICAL RES·Filed 2017·Granted Jun 8, 2021·0 cites·13 claims
- 4943US6410704B1Methods and compositions for the preparation and use of a herpes proteaseARCH DEV CORP·Filed 1994·Granted Jun 25, 2002·5 cites·14 claims
- 5041US2005048491A1Methods and kits for use in selecting approaches to treating cancerFiled 2002·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bernard Roizman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →